ONTX / Onconova Therapeutics, Inc. (ONTX) Reports Q3 Loss, Misses Revenue Estimates

Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Adv more_horizontal

Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Bruce Mackle - Managing Direc more_horizontal

Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This comp more_horizontal

Company to host conference call and webcast at 4:30 p.m. ET on Monday, May 15, 2023 Company to host conference call and webcast at 4:30 p.m. ET on Mon more_horizontal

Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advi more_horizontal

Company to host conference call and webcast at 4:30 p.m. ET on Thursday, March 16, 2023 Company to host conference call and webcast at 4:30 p.m. ET on more_horizontal

NEWTOWN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on disc more_horizontal

Onconova Therapeutics, Inc. (NASDAQ:ONTX ) Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Bruce Mackle - Investor R more_horizontal